Appointments support the Company’s continued focus on life-saving solutions, preparedness, and trusted drug delivery technology
Kaléo, a global leader in drug delivery devices and autoinjectors, has strengthened its leadership team with the appointment of Ram Halthore as Vice President of Development. He joins Carrie Siragusa, CPA, who became Vice President of Marketing and Public Relations last year, underscoring Kaléo’s commitment to investing in leadership that supports innovation, growth, and readiness across its product portfolio.
Health Technology Insights: Abeona Therapeutics Announces Appointment of Mohamad Tabrizi as Chief Business Officer
For more than 25 years, Kaléo has focused on transforming how critical medicines are delivered in high-stress, time-sensitive situations. From designing autoinjectors to assist patients and caregivers during severe allergic emergencies to advancing programs for global health preparedness, the company emphasizes reliability, usability, and trust in all its solutions.
As Vice President of Development, Ram Halthore will oversee the full scope of device and drug development, from initial design through manufacturing transfer. His role includes leading Kaléo’s human factors engineering program, managing integrated drug-device development, and guiding the company’s intellectual property strategy.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 15 December 2025
Michael Wells, Chairman and Chief Executive Officer of Kaléo, said, “As Kaléo continues to evolve as a drug delivery technology company, it is critical to invest in leaders who understand both the science and real-world impact of our Aerio™ autoinjector platform. Ram’s expertise in development, commercialization, and strategic planning strengthens our ability to deliver life-saving, reliable solutions and enhance partnerships as our platform expands.”
Ram brings more than 25 years of experience across medical devices, pharmaceuticals, biologics, and combination products including autoinjectors, prefilled syringes, inhalation devices, implants, and on-body injectors. Before joining Kaléo, he led global technical operations at Merck for the development and commercialization of complex combination products. His career also includes senior roles at Teva, Amgen, Johnson & Johnson, and 3M.
Ram Halthore commented, “Kaléo’s dedication to patient-focused drug-device solutions that perform reliably in real-world situations aligns closely with my background. I am excited to contribute to advancing development programs and partnerships that support patients, caregivers, and emergency responders in moments where clarity and performance are essential.”
In parallel, Kaléo strengthened its commercial strategy by welcoming Carrie Siragusa as Vice President of Marketing and Public Relations. With nearly 20 years of experience spanning marketing, strategy, operations, and finance in biotechnology and pharmaceuticals, Carrie brings expertise in product launches, commercial transformations, and cross-functional leadership.
Together, Ram and Carrie enhance Kaléo’s leadership capacity as the company continues to expand its autoinjector portfolio, advance programs supporting emergency preparedness, and build collaborations across healthcare and government sectors.
Health Technology Insights: Infinitus Launches Next-Generation Clinical AI Agents
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
